Quadrivalent recombinant influenza vaccines contain three times the amount of hemagglutinin protein as standard-dose egg-based vaccines, and the recombinant formulation is not susceptible to antigenic ...

A recent study published in the journal Nature Medicine observed that the recombinant shingles vaccine is associated with reduced dementia risk. Varicella-zoster virus is a herpes virus causing ...

Please provide your email address to receive an email when new articles are posted on . Recombinant herpes zoster vaccine recipients had lower risk for developing dementia compared with those who ...

Receipt of a newer recombinant version of a shingles vaccine is associated with a significant delay in dementia diagnosis in older adults, a new study suggests. The study builds on previous ...

Please provide your email address to receive an email when new articles are posted on . The effectiveness of full vaccination was 73% after 3 to 4 years. In contrast, the effectiveness of partial ...

Among older adults who received at least one dose of the recombinant shingles vaccine, vaccine effectiveness against any herpes zoster-related outcome was 56.1%. Getting a second dose yielded a ...

Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...

People who receive the live-attenuated shingles vaccine may have a lower likelihood of being diagnosed with dementia compared with those who do not get the shot, researchers report April 2 in Nature.